Injectable testosterone suppresses natural production, causing infertility. New protocols use shorter-half-life oral/topical testosterone combined with enclomiphene (which blocks estrogen feedback) to increase T-levels while maintaining the body's own production, making it a viable option for younger men concerned about fertility.

For patients showing a rising PSA shortly after stopping long-term Androgen Deprivation Therapy (ADT), it is crucial to check testosterone levels. They may still be castrated from the prior therapy, meaning their rising PSA actually signifies castration-resistant disease, which requires a completely different treatment approach.

Creatine helps normalize testosterone's conversion pathway, shifting it toward DHT and away from estrogen. For individuals with low 5-alpha reductase activity, it restores a natural balance rather than creating a supraphysiological state that could accelerate hair loss.

For new fathers, neither extremely high nor low testosterone is ideal. Research links very low levels to postpartum depression and very high levels to relationship aggression and stress. A flexible, mid-range level is associated with the most successful outcomes.

The androgen receptor gene, which dictates how the body responds to hormones like testosterone and DHT, is located on the X chromosome. Since men (XY) inherit their X chromosome from their mother, their genetic predisposition for androgen sensitivity is maternally inherited.

Patients can successfully request hormone tests by describing subjective declines in energy, focus, or athletic performance compared to their past selves. This provides the necessary clinical justification for the lab work without requiring a pre-existing diagnosis.

There has been a significant population-level decline in male testosterone. The average level dropped from around 600 ng/dL in the late 1990s to 450 ng/dL by 2015. This is linked to modern lifestyle factors like rising obesity, endocrine-disrupting chemicals, and ultra-processed diets.

The term "hormone resistance" was misleading. Researchers discovered that even in a castrate state, prostate cancer tumors produce their own testosterone locally. This maintained androgen receptor signaling, proving the disease was still "androgen addicted" and opening the door for new targeted therapies.

Within the wide, normal range of testosterone for both men and women, hormone levels are not predictive of one's ability to gain muscle. Only supra-physiological levels, such as those from anabolic steroids, create a significant, predictable advantage in muscle growth.